SC Labs, a company specializing in cannabis testing, has announced plans to expand its operations to Southern California, beginning with the opening of a new laboratory in Los Angeles.
A new facility in the Van Nuys community of Los Angeles spanning over 12,000 square feet will be used for both research and compliance testing of cannabis, similar to a corresponding facility in Santa Cruz. This will provide faster turnaround times and allow for customers south of Santa Barbara to process their samples. The new laboratory will offer a complete range of California-compliant tests including potency, pesticides, heavy metals, residual solvents, microbiologicals, moisture activity, and foreign matter as well as terpene and shelf stability testing. By opening this new state-of-the-art laboratory, SC Labs will offer additional testing capabilities and more research resources.
The new laboratory will operate similar to SC in Santa Cruz, maintaining the same technology stack (laboratory information system and SC customer service portal) and chemical metrology reports for customers to conduct testing on cannabinoids and terpenes. The Los Angeles facility will also offer stability testing to determine the shelf life by February 2023.
Jeff Journey, CEO of SC Labs, expressed enthusiasm for expanding their high-quality testing services to a wider area in California. "With this expansion, we are doubling down on California as a leading market, where we believe regulatory oversight enforces proper testing requirements," he said. "We are excited to begin working in Southern California and providing accurate testing services for more clients as this market continues to mature and develop.
Jeff Gray, co-founder and Chief Innovation Officer of SC Labs, stated, "For years, our clients have requested that we open a laboratory in Southern California and we are thrilled to have finally fulfilled that request. This new state-of-the-art laboratory has doubled our testing capabilities in California, allowing us to engage in more research and development. Importantly, it provides ample and surplus testing capacity for all of our clients.
It is estimated that by 2026, the total sales of medical and recreational marijuana in the United States will surpass $52.6 billion, with California currently being the world's largest legal marijuana market. In regulated marijuana markets such as California, products for sale must undergo a series of tests at nationally accredited laboratories to help ensure their safety and accurate labeling. SC Labs allows clients to meet these requirements and ultimately help them meet market demand.
SC Labs currently has marijuana testing labs in Santa Cruz, California, Colorado, Michigan, and Oregon, in addition to Los Angeles. The company will begin accepting new clients in mid-December and host a formal grand opening in early January. With this growth, SC Labs will hire personnel for two California locations in the new year.
2FIRSTS will continue to provide coverage of this topic, with updates available on the 2FIRSTS app. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
